Early Short‑term Ivabradine Treatment in New‑onset Acute Systolic Heart Failure and Sinus Tachycardia Patients With Inflammatory Rheumatic Disease

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2019.7531
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Ivabradine Added to Guidelines-Based Therapy in Systolic Heart Failure Patients

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2011English

Addressing Major Unmet Needs in Patients With Systolic Heart Failure: The Role of Ivabradine

American Journal of Cardiovascular Drugs
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Prognostic Value of Systolic Short-Term Blood Pressure Variability in Systolic Heart Failure

Clinical Hypertension
2016English

Association of Admission vs. Nadir Serum Albumin Concentration With Short-Term Treatment Outcomes in Patients With Acute Heart Failure

Journal of International Medical Research
BiochemistryMedicineCell Biology
2018English

Ivabradine: Current and Future Treatment of Heart Failure

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Ivabradine, a Novel Treatment for Clozapine-Induced Sinus Tachycardia: A Case Series

Therapeutic Advances in Psychopharmacology
2013English

Influence of Acute Delirium on Short-Term Prognosis in Elderly Acute Decompensated Heart Failure Patients

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Treatment of Congestive Heart Failure Due to Rheumatic Valvular Heart Disease

Japanese Circulation Journal
1973English

P232 Short-Term Outcomes in Heart Failure Patients With Chronic Obstructive Pulmonary Disease in the Community

Thorax
PulmonaryRespiratory Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy